Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,013,114
+$8,540,794 QoQ
Shares Held
27,524
+3.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#678
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Finance, LLC holds $104,508,931 across 9 Drug Manufacturers - General names. LLY ranks #1 (31.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
27,524 | $33,013,114 | |
| 2 | JNJ |
Johnson & Johnson
|
85,199 | $21,637,990 | |
| 3 | ABBV |
AbbVie Inc.
|
61,181 | $15,395,586 | |
| 4 | MRK |
Merck & Co., Inc.
|
93,774 | $12,049,959 | |
| 5 | AMGN |
Amgen Inc
|
18,865 | $6,831,393 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,580 | $5,505,897 | |
| 7 | PFE |
Pfizer Inc
|
197,099 | $4,746,143 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
72,834 | $4,196,695 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,013,114 | 27,524 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,472,320 | 26,607 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,641,299 | 26,651 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $21,454,034 | 28,118 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,561,020 | 27,659 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $22,693,529 | 27,477 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $20,979,100 | 27,175 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $24,398,787 | 27,540 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $24,351,100 | 26,896 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $22,308,780 | 28,676 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $16,153,879 | 27,712 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,791,485 | 27,538 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $11,670,098 | 24,884 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $7,606,409 | 22,149 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $7,695,444 | 21,035 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $6,302,414 | 19,491 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $5,318,668 | 16,404 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $4,450,189 | 15,540 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,855,478 | 13,958 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,387,670 | 10,334 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,976,855 | 8,613 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,609,080 | 8,613 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,454,218 | 8,613 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,075,661 | 7,267 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $148,090 | 902 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $713,159 | 5,141 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||